BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 27236554)

  • 1. Therapeutic Antibodies in Cancer Therapy.
    Gasser M; Waaga-Gasser AM
    Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody therapeutics in cancer.
    Sliwkowski MX; Mellman I
    Science; 2013 Sep; 341(6151):1192-8. PubMed ID: 24031011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.
    Philips GK; Atkins M
    Int Immunol; 2015 Jan; 27(1):39-46. PubMed ID: 25323844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the art in anti-cancer mAbs.
    Chiavenna SM; Jaworski JP; Vendrell A
    J Biomed Sci; 2017 Feb; 24(1):15. PubMed ID: 28219375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors.
    Chester C; Marabelle A; Houot R; Kohrt HE
    Curr Opin Immunol; 2015 Apr; 33():1-8. PubMed ID: 25576932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in gastrointestinal cancers.
    Bronte G; Cicero G; Cusenza S; Galvano A; Musso E; Rizzo S; Sortino G; Roselli M; Bazan V; Fiorentino E; Russo A
    Expert Opin Biol Ther; 2013 Jun; 13(6):889-900. PubMed ID: 23441760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types.
    Ascierto PA; Kalos M; Schaer DA; Callahan MK; Wolchok JD
    Clin Cancer Res; 2013 Mar; 19(5):1009-20. PubMed ID: 23460532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy.
    Callahan MK; Wolchok JD
    J Leukoc Biol; 2013 Jul; 94(1):41-53. PubMed ID: 23667165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeted and immune-targeted monoclonal antibodies: Going from passive to active immunotherapy.
    Marabelle A; Gray J
    Pediatr Blood Cancer; 2015 Aug; 62(8):1317-25. PubMed ID: 25808079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of novel agents in the treatment of colorectal cancer.
    Iqbal S; Lenz HJ
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L
    Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 inhibition with MPDL3280A for solid tumors.
    Cha E; Wallin J; Kowanetz M
    Semin Oncol; 2015 Jun; 42(3):484-7. PubMed ID: 25965367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibodies for the Treatment of Cancer.
    Pento JT
    Anticancer Res; 2017 Nov; 37(11):5935-5939. PubMed ID: 29061772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Mateus C; Libenciuc C; Robert C
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S4-S11. PubMed ID: 27494973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Therapies in Cancer.
    Wang S; Jia M
    Adv Exp Med Biol; 2016; 909():1-67. PubMed ID: 27240456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
    Shapira S; Lisiansky V; Arber N; Kraus S
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies.
    Keung EZ; Wargo JA
    Surg Oncol Clin N Am; 2019 Jul; 28(3):369-386. PubMed ID: 31079794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.